Platinum Resistant Ovarian Cancer Proc clinical trials

Explore recruiting platinum resistant ovarian cancer proc clinical trials.

Recruiting platinum resistant ovarian cancer proc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Platinum Resistant Ovarian Cancer Proc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator’s Choice (IC) in Patients with Platinum Resistant Ovarian Cancer

Spain, Norway, Czechia, Netherlands, Germany, Belgium +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Denmark, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Platinum Resistant Ovarian Cancer Proc trials by city

Platinum Resistant Ovarian Cancer Proc in Toronto Platinum Resistant Ovarian Cancer Proc in Vancouver Platinum Resistant Ovarian Cancer Proc in Montreal Platinum Resistant Ovarian Cancer Proc in Calgary Platinum Resistant Ovarian Cancer Proc in Edmonton Platinum Resistant Ovarian Cancer Proc in Ottawa Platinum Resistant Ovarian Cancer Proc in Winnipeg Platinum Resistant Ovarian Cancer Proc in Quebec City Platinum Resistant Ovarian Cancer Proc in Hamilton Platinum Resistant Ovarian Cancer Proc in Kitchener Platinum Resistant Ovarian Cancer Proc in London Platinum Resistant Ovarian Cancer Proc in Halifax Platinum Resistant Ovarian Cancer Proc in New York Platinum Resistant Ovarian Cancer Proc in Los Angeles Platinum Resistant Ovarian Cancer Proc in Chicago Platinum Resistant Ovarian Cancer Proc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease